FDA OKs Bristol Myers Squibb’s Lag-3 drug, approving first new class of checkpoint inhibitor in 8 years

Media coverage

• Title	FDA OKs Bristol Myers Squibb’s Lag-3 drug, approving first new class of checkpoint inhibitor in 8 years
  Media name/outlet	Endpts.com
  Country/Territory	United States
  Date	18/03/22
  URL	https://endpts.com/fda-oks-bristol-myers-squibbs-lag-3-drug-approving-first-new-class-of-checkpoint-inhibitor-in-8-years/
  Persons	Miriam Merad